跳至主要内容
临床试验/2025-522809-38-00
2025-522809-38-00招募中3 期

Continuous antibiotic infusion in children

Pirkanmaan hyvinvointialue1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2026年2月16日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
150
试验地点
1
主要终点
Possible relapse (defined separately for each patient case)

研究概览

简要总结

To evaluate the efficacy, safety and cost-efficiency of continuous (24 h) antibiotic infusion in children

入排标准

年龄范围
0 years 至 17 years(0-17 Years)
接受健康志愿者

入选标准

  • Iv-antibiotic treatment is necessary
  • Clinically stable
  • No need to stay in hospital
  • Pump or cassette can be changed at the hospital or at home
  • Care givers are able to contact hospital if needed
  • Clinical diagnose is not uncertain
  • No allergy for the used antibiotic
  • The continuous antibiotic infusion hasn’t been started yet or it has been initiated no more than 24 hours prior to study enrolment

排除标准

  • The pump cannot be carried with the child
  • The child must stay at the hospital for monitoring or other reason
  • Unclear diagnose

结局指标

主要结局

Possible relapse (defined separately for each patient case)

Possible relapse (defined separately for each patient case)

Duration of hospital stay / fever / antibiotic treatment

Duration of hospital stay / fever / antibiotic treatment

Readmission to hospital

Readmission to hospital

次要结局

未报告次要终点

研究者

发起方
Pirkanmaan hyvinvointialue
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Maria Pohjanpää

Scientific

Pirkanmaan hyvinvointialue

研究点 (1)

Loading locations...

相似试验

Continuous antibiotic infusion in children | 临床试验